`
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________
`
`MYLAN PHARMACEUTICALS INC., and
`DR. REDDY’S LABORATORIES, INC.
`
`Petitioners
`
`v.
`
`HORIZON PHARMA USA, INC. and NUVO PHARMACEUTICALS
`(IRELAND) DESIGNATED ACTIVITY COMPANY,
`Patent Owners.
`____________________________
`
`Case No. IPR2017-019951
`U.S. Patent No. 9,220,698
`____________________________
`
`JOINT REQUEST THAT SETTLEMENT AGREEMENT BE TREATED AS
`BUSINESS CONFIDENTIAL INFORMATION AND KEPT SEPARATE
`PURSUANT TO 35 U.S.C. § 317(b) AND 37 C.F.R. § 42.74(c)
`
`
`
`
`1 Petitioner Dr. Reddy’s Laboratories, Inc., from IPR2018-00894, has been joined as
`
`a Petitioner to this proceeding.
`
`
`
`
`
`Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c), Petitioner Mylan
`
`Pharmaceuticals Inc. (“Mylan”) and Patent Owners Horizon Pharma USA, Inc. and
`
`Nuvo Pharmaceuticals (Ireland) Designated Activity Co. (“Patent Owners”) jointly
`
`request that the settlement agreement filed concurrently herewith (Ex. 1059) and
`
`referenced in the concurrently-filed Joint Motion to Terminate Petitioner Mylan
`
`Pharmaceuticals Inc. be treated as business confidential information and kept
`
`separate from the files of the involved patent and only made available to Federal
`
`Government agencies upon written request or to any other person upon written
`
`request and a showing of good cause.
`
`Dated: July 29, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`Reg. No. 52,354
`PERKINS COIE LLP
`700 13th Street, NW, Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6206
`Facsimile: (202) 654-6211
`Email: bmwhite@perkinscoie.com
`Attorney for Mylan Pharmaceuticals Inc.
`
`1
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that the foregoing Joint Request That
`
`Settlement Agreement Be Treated as Business Confidential Information and Kept
`
`Separate Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c) and Exhibit 1059
`
`was served electronically via email as follows:
`
`Thomas A. Blinka
`Jonathan G. Graves
`Ellen Scordino
`Cooley LLP
`zIPR2017-01995@cooley.com
`
`Margaret J. Sampson
`Stephen M. Hash
`Jeffrey S. Gritton
`Baker Botts LLP
`nuvo-vimovoBB@bakerbotts.com
`
`The undersigned hereby certifies that the foregoing Joint Request That
`
`Settlement Agreement Be Treated as Business Confidential Information and Kept
`
`Separate Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c) (without Exhibit
`
`1059) was served electronically via email as follows:
`
`Alan H. Pollack
`Stuart D. Sender
`Louis H. Weinstein
`Windels Marx Lane & Mittendorf, LLP
`apollack@windelsmarx.com
`ssender@windelsmarx.com
`lweinstein@windelsmarx.com
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`Reg. No. 52,354
`Attorney for Mylan Pharmaceuticals Inc.
`
`
`
`Date: July 29, 2019
`
`
`
`